← FDA DRUG APPROVALS

FDA ANDA · ANDA200489

NORETHINDRONE AND ETHINYL ESTRADIOL

Sponsor: MYLAN LABS LTD

APPLICATION
ANDA200489
TYPE
ANDA
ORIGINAL APPROVAL
2015-10-21
LATEST ACTION
2016-08-22
ROUTE
ORAL-28
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

NORETHINDRONE AND ETHINYL ESTRADIOLDiscontinued
ETHINYL ESTRADIOL 0.035MG, NORETHINDRONE 1MG · TABLET · ORAL-28

Approval history

2016-08-22Labeling · Supplement 1 · standardAP
2015-10-21Not Applicable · OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →